產(chǎn)品展示
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1773
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1816
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:2014
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1819
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1702
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1813
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1800
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1946

